谁是全球药王?半年狂揽166亿美元,诺和诺德司美格鲁肽力压默沙东K药

时代财经
Aug 06, 2025

本文来源:时代财经8月6日,时代财经获悉,诺和诺德发布2025年上半年财报。今年上半年,公司实现营收1549.44亿丹麦克朗(约合228.54亿美元),同比增长18%;中国区收入99.10亿丹麦克朗(约合14.62亿美元),同比增长6%。其中,王牌单品司美格鲁肽上半年销售额高达1127.56亿丹麦克朗(约合166.32亿美元),占诺和诺德总营收的73%。这一数字超过昔日全球“药王”默沙东的帕博利珠...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10